Pharmaceutical Sector

MSD India to offer employment to 300 persons by end of this year

MSD India to offer employment to 300 persons by end of this yearMSD India, a wholly-owned subsidiary of US drug maker Merck & Co, has revealed its plans to hire 300 people by December end this year.

The new hiring will be spread across all areas of its operations.

Presently, the company has staff strength of about 700 employees, which it wants to raise to 1000 by end of this year.

Apart from latest revealed move, the company is also looking to expand its presence in the Indian market, where it intends to introduce more vaccines.

Aurobindo gets nod for Tenofovir Disoproxil Fumarate Tablets

Aurobindo gets nod for Tenofovir Disoproxil Fumarate Tablets Hyderabad-based drug maker Aurobindo Pharmaceuticals has notified that it has received US regulatory approval for Tenofovir Disoproxil Fumarate tablets, used in the treatment of HIV infections in adults.

It should be noted that Tenofovir Disoproxil Fumarate tablet, is the generic equivalent of Gilead Science Inc's Viread Tablet 300mg and falls under the anti-retroviral segment.

The company has already obtained a license from Gilead to market Tenofovir products in 95 developing and least developed countries.

France's Sanofi-Aventis set to take over Czech drugmaker Zentiva

France's Sanofi-Aventis set to take over Czech drugmaker Zentiva Prague  - French pharmaceutical group Sanofi-Aventis is set to take control of the Czech generics maker Zentiva as smaller shareholders agreed to sell their stakes in the company.

Czech financial group J&T, which holds a 7.6 per cent stake in Zentiva through a subsidiary, said Friday it had accepted Sanofi- Aventis' buyout offer of 1,150 koruny (51 dollars) per share.

Glaxo posts 157% increase in net for Q4

Glaxo posts 157% increase in net for Q4Glaxo Pharmaceuticals reported 157 per cent increase in net profit for the fourth quarter ended December 31, 2008 due to significant increase in its income during the reporting period.

The company posted net profit of Rs 208.4 crore against Rs 80.9 crore in the same period last year, despite recession like situation across the world. Its total income stood at Rs 1742.6 crore, posting increase of 5.31 per cent as compared to total income of Rs 1654.6 crore for the fourth quarter in 2007.

GSK Q4 Net Profit Increases To Rs 208 Cr

GSK Q4 Net Profit Increases To Rs 208 CrGlaxosmithkline Pharmaceuticals announced its quarterly results for the period ending December 31, 2008. It posted 157 per cent increase in net profit for the third quarter of current financial year.

The company has posted a net profit of Rs 208.4 crore for the fourth quarter, as against Rs 80.9 crore during the corresponding period last fiscal.

During the quarter, the company said that its income from operations rose to Rs 374.8 crore in December quarter, where as the same was at Rs 346.7 crore in the previous year.

Egyptian pharmacies strike for second day against new tax law

Egyptian pharmacies strike for second day against new tax lawCairo  - Many privately owned pharmacies were engaged in a second day of strikes Tuesday in a row to protest efforts by authorities to enforce a new tax law.

Some pharmacies had signs on their closed doors saying: "The pharmacy is closed in protest against the bad treatment of the Income Tax Authority against the Egyptian people."

Pages